More about Jubilant Pharmova Limited
Fundamentals for Jubilant Pharmova Limited
Regulatory Filings for Jubilant Pharmova Limited
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy
The Hidden Engine of Global Growth: Why India Is Becoming Impossible to Overlook
₹10,000 Crore Deep-Tech Pivot: Why Fund of Funds 2.0 Will Redraw India's Startup Map
Regulatory Filings for Jubilant Pharmova Limited
Recent filings by Jubilant Pharmova Limited
| Published | Title | Summary |
|---|---|---|
| 2026-04-24 18:42:32 | Board Meeting Intimation | JUBILANT PHARMOVA LIMITED has informed the Exchange about Board Meeting... |
| 2025-12-30 17:52:25 | Acquisition-XBRL | JUBILANT PHARMOVA LIMITED has informed the Exchange regarding Acquisition... |
| 2025-12-30 17:49:26 | Acquisition | Jubilant Pharmova Limited has informed the Exchange about Acquisition... |
| 2025-01-23 11:23:50 | Board Meeting Intimation | JUBILANT PHARMOVA LIMITED has informed the Exchange about Board Meeting... |
| 2024-10-17 18:26:49 | Board Meeting Intimation | JUBILANT PHARMOVA LIMITED has informed the Exchange about Board Meeting... |
| 2024-10-04 21:53:19 | Acquisition-XBRL | JUBILANT PHARMOVA LIMITED has informed the Exchange regarding Acquisition... |
| 2024-10-04 17:51:00 | Acquisition | Jubilant Pharmova Limited has informed the Exchange about Acquisition... |
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
India's Silent AI Revolution: Tiny Models Powering Kirana Stores and Tier-3 Boom
Is the Petrodollar Cracking? How India Paying Iran in Yuan Could Reshape Global Power
Forget the Unicorn Circus - India's Best Startup IPOs of 2026 Are Built on Boring, Beautiful Fundamentals
